FindTrial
Sign In

IBS-C Study A2306

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN47368803
Enrollment
Unknown
Registered
2003-09-11
Start date
2002-04-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome (IBS) with constipation Digestive System Irritable bowel syndrome (IBS) with constipation

Interventions

Not provided at time of registration.

Sponsors

Novartis Pharmaceuticals Corporation
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Females, 18 to 65 years, with IBS-C (Irritable Bowel Syndrome with constipation)

Exclusion criteria

Exclusion criteria: Not provided at time of registration.

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration.—

Secondary

MeasureTime frame
Not provided at time of registration.—

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026